Comparison of the efficacy and safety of transarterial chemoembolization with and without apatinib for the treatment of BCLC Stage C hepatocellular carcinoma

被引：0
|
作者：
Chen, S. [1 ,2 ]
机构：
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Canc Hosp, Dept Intervent Oncol, Fuzhou, Fujian, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
379 (PB-04
引用
收藏
页码：E123 / E123
页数：1
相关论文
共 50 条
  • [1] Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
    Chen, Shiguang
    Yu, Wenchang
    Zhang, Kongzhi
    Liu, Weifu
    BMC CANCER, 2018, 18
  • [2] Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
    Shiguang Chen
    Wenchang Yu
    Kongzhi Zhang
    Weifu Liu
    BMC Cancer, 18
  • [3] Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study
    Xia, Wei-Li
    Zhao, Xiao-Hui
    Yuan-Guo, Yuan-
    Cao, Guang-Shao
    Wu, Gang
    Fan, Wei-Jun
    Yao, Quan-Jun
    Xu, Shi-Jun
    Guo, Chen-Yang
    Hu, Hong-Tao
    Li, Hai-Liang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma
    Wu, Juan
    Zeng, Jia
    Wang, Huiwen
    Huo, Zhuoni
    Hou, Xunbo
    He, Dongfeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
    Liu, Kai-Cai
    Hao, Ying-Hong
    Lv, Wei-Fu
    Jia, Wei-Dong
    Ji, Chu-Shu
    Zhou, Chun-Ze
    Cheng, De-Lei
    Xu, Shao-Bao
    Gao, Zong-Gen
    Su, Ming-Xue
    Shi, Chang-Sheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3461 - 3468
  • [6] Surgical Resection Versus Transarterial Chemoembolization for BCLC Stage C Hepatocellular Carcinoma
    Liu, Po-Hong
    Hsia, Cheng-Yuan
    Lee, Yun-Hsuan
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lee, Rheun-Chuan
    Lin, Han-Chieh
    Huo, Teh-Ia
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (04) : 404 - 409
  • [7] The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Chen, Lei
    Sun, Tao
    Wu, Linxia
    Zhang, Weihua
    Ren, Yanqiao
    Xiang, Dongqiao
    Liang, Bin
    Zheng, Chuansheng
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [8] Efficacy and safety of apatinib plus immune checkpoint inhibitors and transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma
    Wu, Jianfei
    Bai, Xuefeng
    Yu, Guodong
    Zhang, Quan
    Tian, Xixi
    Wang, Yuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (07)
  • [9] A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
    Mei, Jie
    Li, Shao-Hua
    Wang, Qiao-Xuan
    Zhong, Xiao-Ping
    Lu, Liang-He
    Kan, Anna
    Wei, Wei
    Guo, Rong-Ping
    CANCER MEDICINE, 2020, 9 (01): : 62 - 76
  • [10] Comment on: Surgical Resection Versus Transarterial Chemoembolization for BCLC Stage C Hepatocellular Carcinoma
    Wang, Yan-Yan
    Zhong, Jian-Hong
    Qin, Hong-Gui
    Li, Le-Qun
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (08) : 907 - 908
12345